Data only

A compact side-by-side comparison · suggested for this question

Success rate

Clinical trial success across retinal and bionic devices%

Early trials achieved transition success as high as 84.8% in Phase I, while specific functional tasks dropped to just 5% when devices were turned off.

Web search · verify18 values

The numbers

18 rows
Success rate (%). Source: Clinical Development Success Rates and Contributing Factors 2011–2020 - BIO.
1Phase I Transition Success Rate (BIO 2006-2015)84.8
2Retinal Prosthesis Simulation Irregularity-Optimized Character Recognition Rate80
3Phase I Transition Success Rate (Wong et al. 2000-2015)73.7
4Phase I Transition Success Rate (BIO 2011-2020)71.6
5Phase II Transition Success Rate (Wong et al. 2000-2015)71.4
6Argus II Retinal Prosthesis Line Task Success (Device ON, 5-Year Follow-up)70
7Argus II Clinical Study Line Task Success Rate (Device ON - AHRQ Review)68
8Epiretinal Prosthesis Door Localization Task Success (Device ON - NICE Overview)60
9Argus II Clinical Study Door Task Success Rate (Device ON - AHRQ Review)54
10Argus II Retinal Prosthesis Door Task Success (Device ON, 5-Year Follow-up)50
1160-Electrode Retinal Prosthesis Sock Classification Task Success Rate50
12Phase III Transition Success Rate (Thomas et al. / Ophthalmology Benchmark)47
13Phase II Transition Success Rate (Thomas et al. / Ophthalmology Benchmark)36
14Argus II Clinical Study Door Task Success Rate (Device OFF - AHRQ Review)27
15Argus II Clinical Study Line Task Success Rate (Device OFF - AHRQ Review)23
16Argus II Retinal Prosthesis Door Task Success (Device OFF, 5-Year Follow-up)20
17Argus II Retinal Prosthesis Line Task Success (Device OFF, 5-Year Follow-up)20
18Epiretinal Prosthesis Door Localization Task Success (Device OFF - NICE Overview)5

About this data

Where it's from
Clinical Development Success Rates and Contributing Factors 2011–2020 - BIO
How it was found
Collected by grounded web search
Retrieved
Nov 15, 2026, 2:17 AM
Saved
15 Nov 2026

More charts

Browse every chart